Cite
HARVARD Citation
Moore, D. et al. (2019). Incidence and management of adverse events associated with panobinostat in the treatment of relapsed/refractory multiple myeloma. Journal of oncology pharmacy practice. pp. 613-622. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Moore, D. et al. (2019). Incidence and management of adverse events associated with panobinostat in the treatment of relapsed/refractory multiple myeloma. Journal of oncology pharmacy practice. pp. 613-622. [Online].